Hyperfine, Inc.

Hyperfine, Inc. completed its business combination with HealthCare Special Purpose Acquisition Corp (Nasdaq: HCAQ), sponsored by HealthCare Special Purpose Acquisition Partners, LLC, in December 2021, bringing the medical-technology company to the public markets via a healthcare-sector SPAC that conducted its IPO earlier that year. Hyperfine develops portable, low-field magnetic resonance imaging systems designed to broaden point-of-care neuroimaging access, placing it in the medical-device segment of the life sciences industry. The company filed an 8-K current report with the Securities and Exchange Commission on May 12, 2026, continuing its ongoing public-company disclosure obligations following the de-SPAC transaction. Sign up for SpacDesk to access the full filing history, deal timelines, and real-time data on Hyperfine and every active SPAC transaction in the market.